Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
The Clinical Neuropsychologist|June 4, 2019
The brief Dimensional Apathy Scale: A short clinical assessment of apathyRatko Radakovic, Sarah McGrory, Siddharthan Chandran, et al.Journal of Neurology|February 27, 2019
Changing epidemiology of motor neurone disease in ScotlandDanielle J Leighton, Judith Newton, Laura J Stephenson, et al.Current Medicinal Chemistry|January 29, 2008
The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failureEttore Beghi, Tiziana Mennini, Caterina Bendotti, et al.Molecular and Cellular Probes|June 12, 2016
Improved PCR based methods for detecting C9orf72 hexanucleotide repeat expansionsElaine M Cleary, Suvankar Pal, Tara Azam, et al.Neurobiology of Disease|September 25, 2002
CuZn-superoxide dismutase in D90A heterozygotes from recessive and dominant ALS pedigreesP Andreas Jonsson, Asa Bäckstrand, Peter M Andersen, et al.Nature Genetics|February 28, 2006
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosisMatthew J Greenway, Peter M Andersen, Carsten Russ, et al.Journal of Neurology|June 9, 2024
Genotypes and phenotypes of motor neuron disease: an update of the genetic landscape in ScotlandDanielle J Leighton, Morad Ansari, Judith Newton, et al.Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 12, 2010
The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trialsEttore Beghi, Adriano Chiò, Philippe Couratier, et al.Neurobiology of Aging|January 17, 2017
Genetic epidemiology of motor neuron disease-associated variants in the Scottish populationHolly A Black, Danielle J Leighton, Elaine M Cleary, et al.Neurology|September 14, 2018
ALS-specific cognitive and behavior changes associated with advancing disease stage in ALSChristopher Crockford, Judith Newton, Katie Lonergan, et al.Pageof 3